Reports for ALLERGAN INC

Company Name

ALLERGAN INC

Totals

Shortage reports

71

Actual shortage: 1 (1%)
Anticipated shortage: 0 (0%)
Avoided shortage: 3 (4%)
Resolved: 67 (94%)

Discontinuation Reports

4

To be discontinued: 0 (0%)
Discontinued: 4 (100%)
Reversed: 0 (0%)

Late reports

8 (11%)

Overdue reports

0 (0%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
LUMIGAN 0.03% SOLUTION Actual shortage 2017-04-05 2017-10-05 5736
TAZORAC 0.05% GEL Resolved 2018-11-01 2019-05-18 65978
TAZORAC 0.05% CREAM Resolved 2018-11-02 2018-12-01 66116
TAZORAC 0.05% CREAM Resolved 2019-09-16 2019-11-08 93944
RESTASIS MULTIDOSE 0.05% EMULSION Resolved 2019-02-01 2020-03-19 74356
FML 0.1% 0.1% DROPS Resolved 2019-08-14 2019-09-21 91579
FML 0.1% 0.1% DROPS Resolved 2019-10-24 2019-11-08 97085
FML 0.1% 0.1% DROPS Resolved 2020-02-10 2020-03-05 105623
FML 0.1% 0.1% DROPS Resolved 2020-03-25 2020-04-22 109342
TAZORAC 0.1% GEL Resolved 2018-11-02 2018-12-01 66125
TAZORAC 0.1% CREAM Resolved 2019-09-16 2020-03-10 93947
ALPHAGAN P 0.15% SOLUTION Resolved 2019-01-21 2019-01-23 73016
ALPHAGAN P 0.15% SOLUTION Resolved 2019-10-24 2019-11-08 97088
ALPHAGAN P 0.15% SOLUTION Resolved 2019-12-07 2020-02-05 100498
BLEPHAMIDE 0.2% 10% DROPS Resolved 2018-02-19 2018-04-21 40184
BLEPHAMIDE 0.2% 10% DROPS Resolved 2018-02-19 2018-04-21 40187
BLEPHAMIDE 0.2% 10% DROPS Resolved 2019-03-03 2019-04-15 77338
BLEPHAMIDE 0.2% 10% DROPS Resolved 2019-03-03 2019-04-19 77342
BLEPHAMIDE 0.2% 10% DROPS Resolved 2019-10-24 2019-11-08 97094
BLEPHAMIDE S.O.P. 0.2% 10% OINTMENT Resolved 2018-02-19 2019-11-08 40190

Showing 1 to 20 of 71

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
BLEPHAMIDE S.O.P. 0.2% 10% OINTMENT Discontinued 2019-07-31 2019-07-31 90343
BETAGAN OPH SOLN 0.25% 0.25% LIQUID Discontinued 2017-08-04 2017-08-04 18275
ALOCRIL 2% LIQUID Discontinued 2018-11-28 2019-04-02 67803
BETAGAN 0.5% OPHTHALMIC SOL 5MG LIQUID Discontinued 2020-03-10 2020-03-10 108380